Table I.
LncRNA HOTAIR expression and the clinicopathological features of the patients with OS.
| HOTAIR expression (no. of patients) | ||||
|---|---|---|---|---|
| Variable | No. of patients (%) | Low (%) | High (%) | P-value |
| Age (years) | 0.795 | |||
| <20 | 34 (100) | 16 (47) | 18 (53) | |
| ≥20 | 26 (100) | 14 (54) | 12 (46) | |
| Gender | 0.599 | |||
| Male | 38 (100) | 22 (58) | 16 (42) | |
| Female | 22 (100) | 11 (50) | 11 (50) | |
| Tumor size (cm) | 1.000 | |||
| ≥10 | 20 (100) | 10 (50) | 10 (50) | |
| <10 | 40 (100) | 19 (48) | 21 (52) | |
| Tumor grade | 0.035 | |||
| I | 9 (100) | 7 (78) | 2 (22) | |
| II | 15 (100) | 6 (40) | 9 (60) | |
| III | 36 (100) | 11 (31) | 25 (69) | |
| Distant metastasis | 0.007 | |||
| Absent | 37 (100) | 27 (73) | 10 (27) | |
| Present | 23 (100) | 8 (35) | 15 (65) | |
Tumor grading was defined according to the World Health Organization classification system (30). HOTAIR, Hox transcript antisense intergenic RNA.